2025
Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012–22
Beetham T, Newton H, Ndumele C, Fiellin D, Busch S. Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012–22. Health Affairs 2025, 44: 1122-1130. PMID: 40893069, DOI: 10.1377/hlthaff.2025.00348.Peer-Reviewed Original ResearchConceptsMedicaid patients' accessDifference-in-differences frameworkResidential addiction treatmentIntervention statesResidential addiction treatment facilityMOUD availabilityPolicy effectsProvider entrySurvey dataMedicaid fundingMedicaid participationMedicaid beneficiariesPolicyAddiction treatment facilitiesMedicaidTreatment marketAddiction treatmentWaiverOpioid use disorderMedicaid patientsMOUDUse disorderStateFacility entryBeneficiaries
2015
Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial
D’Onofrio G, O’Connor P, Pantalon MV, Chawarski MC, Busch SH, Owens PH, Bernstein SL, Fiellin DA. Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA 2015, 313: 1636-1644. PMID: 25919527, PMCID: PMC4527523, DOI: 10.1001/jama.2015.3474.Peer-Reviewed Original ResearchConceptsBrief intervention groupOpioid-dependent patientsIllicit opioid useAddiction treatment servicesPercent of patientsBuprenorphine groupEmergency departmentIntervention groupReferral groupOpioid useTreatment servicesBrief interventionOpioid dependenceClinical trialsHIV riskUrban teaching hospital emergency departmentBuprenorphine/naloxone treatmentHuman immunodeficiency virus (HIV) riskTeaching hospital emergency departmentAddiction treatmentBuprenorphine treatment groupUrine samplesBuprenorphine/naloxoneRandomized clinical trialsCommunity-based treatment services
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply